tradingkey.logo

Myomo Inc

MYO
0.863USD
+0.022+2.67%
Fechamento 11/05, 16:00ETCotações atrasadas em 15 min
32.60MValor de mercado
PerdaP/L TTM

Mais detalhes de Myomo Inc Empresa

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.

Informações de Myomo Inc

Código da empresaMYO
Nome da EmpresaMyomo Inc
Data de listagemJun 12, 2017
CEOMr. Paul R. Gudonis
Número de funcionários184
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 12
Endereço137 Portland Street
CidadeBOSTON
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal02114
Telefone16179969058
Sitehttps://myomo.com/
Código da empresaMYO
Data de listagemJun 12, 2017
CEOMr. Paul R. Gudonis

Executivos da empresa Myomo Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
474.42K
+26.71%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
474.42K
+26.71%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
Por EmpresaUSD
Nome
Receita
Proporção
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%

Distribuição de ações

Atualizado em: sáb, 1 de nov
Atualizado em: sáb, 1 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Rosalind Advisors, Inc.
9.51%
Herr Investment Group LLC
7.53%
Triple Gate Capital, LP
7.47%
BlackRock Institutional Trust Company, N.A.
4.00%
The Vanguard Group, Inc.
3.94%
Outro
67.55%
Investidores
Investidores
Proporção
Rosalind Advisors, Inc.
9.51%
Herr Investment Group LLC
7.53%
Triple Gate Capital, LP
7.47%
BlackRock Institutional Trust Company, N.A.
4.00%
The Vanguard Group, Inc.
3.94%
Outro
67.55%
Tipos de investidores
Investidores
Proporção
Hedge Fund
22.96%
Investment Advisor
22.00%
Investment Advisor/Hedge Fund
10.68%
Individual Investor
7.42%
Research Firm
2.77%
Venture Capital
0.16%
Pension Fund
0.16%
Bank and Trust
0.09%
Outro
33.75%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
153
22.25M
58.86%
-1.76M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
2023Q3
64
15.22M
79.76%
+6.49M
2023Q2
62
8.10M
62.40%
+2.44M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Rosalind Advisors, Inc.
3.60M
9.51%
+892.13K
+33.00%
Jun 30, 2025
Herr Investment Group LLC
2.85M
7.53%
+1.20M
+72.93%
Jun 30, 2024
Triple Gate Capital, LP
2.83M
7.47%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.51M
4%
+1.40M
+1213.08%
Jun 30, 2025
The Vanguard Group, Inc.
1.49M
3.94%
+226.35K
+17.94%
Jun 30, 2025
Gudonis (Paul R)
1.25M
3.3%
-10.00K
-0.79%
Sep 09, 2025
Journey Advisory Group, LLC
875.84K
2.32%
-248.95K
-22.13%
Jun 30, 2025
Worth Venture Partners, LLC
875.76K
2.32%
-312.69K
-26.31%
Jun 30, 2025
Soleus Capital Management, L.P.
704.27K
1.86%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
669.28K
1.77%
+412.63K
+160.78%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
Proporção0.01%
ProShares Hedge Replication ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
iShares Russell 2000 Growth ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
ProShares UltraPro Russell2000
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI